Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions

ObjectiveThis study aimed to compare the variability of HPV16/18/52/58 subtype infections in patients with different cervical lesions, to explore the guiding significance of persistent positive HPV subtypes 52 and 58 in the stratified management of cervical lesions, and to determine the appropriate...

Full description

Bibliographic Details
Main Authors: Baozhu Yi, Qian Xu, Zhixuan Zhang, Jinyi Zhang, Yi Xu, Luoqi Huang, Yue Hu, Quanmei Tu, Jingyun Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.812076/full
_version_ 1811247357386293248
author Baozhu Yi
Qian Xu
Zhixuan Zhang
Jinyi Zhang
Yi Xu
Luoqi Huang
Yue Hu
Quanmei Tu
Jingyun Chen
author_facet Baozhu Yi
Qian Xu
Zhixuan Zhang
Jinyi Zhang
Yi Xu
Luoqi Huang
Yue Hu
Quanmei Tu
Jingyun Chen
author_sort Baozhu Yi
collection DOAJ
description ObjectiveThis study aimed to compare the variability of HPV16/18/52/58 subtype infections in patients with different cervical lesions, to explore the guiding significance of persistent positive HPV subtypes 52 and 58 in the stratified management of cervical lesions, and to determine the appropriate management model.MethodThis study was conducted through a retrospective analysis of 244,218 patients who underwent HPV testing at the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University from September 2014 to December 2020 to examine the distribution of different types of HPV infection. From March 2015 to September 2017, 3,014 patients with known HPV underwent colposcopy to analyze high-risk HPV infection for different cervical lesions. Meanwhile, from September 2014 to December 2020, 1,616 patients positive for HPV16/18/52/58 alone with normal TCT who underwent colposcopy in our hospital were retrospectively analyzed for the occurrence of cervical and vulvovaginal lesions, with colposcopic biopsy pathology results serving as the gold standard for statistical analysis.ResultAnalysis of 244,218 patients who had HPV tested revealed that the top 3 high-risk HPV types were HPV52, HPV58, and HPV16. Further analysis of 3,014 patients showed that 78.04% of patients referred for colposcopy had HPV16/18/52/58 alone. Among high-grade squamous intraepithelial lesions (HSIL) and cervical cancer, the most common is HPV16, followed by HPV58 and then HPV52 (p < 0.05). A total of 1,616 patients with normal TCT who were referred for colposcopy due to HPV16/18/52/58 infection were further analyzed. Based on pathological findings in lesions of HSIL and CC, HPV16 is the most common, followed by HPV58 and then HPV18 (p < 0.05). In the 1,616 patients analyzed, high-grade vulvovaginal lesions were detected, with HPV58 being the most common, followed by HPV16 and then HPV52 (p < 0.05).Conclusion1. In patients with positive HPV58 alone and normal TCT, the indications for colposcopy may be relaxed, with particular attention paid to the possibility of vulvar and vaginal lesions.2. Patients with a positive HPV type 52 alone and normal TCT may be considered for a follow-up review and, if necessary, a colposcopy.3. The development of a more suitable HPV vaccine for the Asian population, such as HPV16/18/52/58, may better protect women’s health.
first_indexed 2024-04-12T15:07:23Z
format Article
id doaj.art-24333f716b6d4c739018b2b0ee077da7
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T15:07:23Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-24333f716b6d4c739018b2b0ee077da72022-12-22T03:27:52ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-05-011210.3389/fonc.2022.812076812076Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical LesionsBaozhu Yi0Qian Xu1Zhixuan Zhang2Jinyi Zhang3Yi Xu4Luoqi Huang5Yue Hu6Quanmei Tu7Jingyun Chen8Department of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Gynecology, Yiwu Maternity and Children Health Care Hospital, Jinhua, ChinaDepartment of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, ChinaObjectiveThis study aimed to compare the variability of HPV16/18/52/58 subtype infections in patients with different cervical lesions, to explore the guiding significance of persistent positive HPV subtypes 52 and 58 in the stratified management of cervical lesions, and to determine the appropriate management model.MethodThis study was conducted through a retrospective analysis of 244,218 patients who underwent HPV testing at the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University from September 2014 to December 2020 to examine the distribution of different types of HPV infection. From March 2015 to September 2017, 3,014 patients with known HPV underwent colposcopy to analyze high-risk HPV infection for different cervical lesions. Meanwhile, from September 2014 to December 2020, 1,616 patients positive for HPV16/18/52/58 alone with normal TCT who underwent colposcopy in our hospital were retrospectively analyzed for the occurrence of cervical and vulvovaginal lesions, with colposcopic biopsy pathology results serving as the gold standard for statistical analysis.ResultAnalysis of 244,218 patients who had HPV tested revealed that the top 3 high-risk HPV types were HPV52, HPV58, and HPV16. Further analysis of 3,014 patients showed that 78.04% of patients referred for colposcopy had HPV16/18/52/58 alone. Among high-grade squamous intraepithelial lesions (HSIL) and cervical cancer, the most common is HPV16, followed by HPV58 and then HPV52 (p < 0.05). A total of 1,616 patients with normal TCT who were referred for colposcopy due to HPV16/18/52/58 infection were further analyzed. Based on pathological findings in lesions of HSIL and CC, HPV16 is the most common, followed by HPV58 and then HPV18 (p < 0.05). In the 1,616 patients analyzed, high-grade vulvovaginal lesions were detected, with HPV58 being the most common, followed by HPV16 and then HPV52 (p < 0.05).Conclusion1. In patients with positive HPV58 alone and normal TCT, the indications for colposcopy may be relaxed, with particular attention paid to the possibility of vulvar and vaginal lesions.2. Patients with a positive HPV type 52 alone and normal TCT may be considered for a follow-up review and, if necessary, a colposcopy.3. The development of a more suitable HPV vaccine for the Asian population, such as HPV16/18/52/58, may better protect women’s health.https://www.frontiersin.org/articles/10.3389/fonc.2022.812076/fullcervical lesionshuman papillomavirus (HPV)colposcopic biopsyhuman papillomavirus 52 (HPV52)human papillomavirus 58cervical cancer
spellingShingle Baozhu Yi
Qian Xu
Zhixuan Zhang
Jinyi Zhang
Yi Xu
Luoqi Huang
Yue Hu
Quanmei Tu
Jingyun Chen
Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
Frontiers in Oncology
cervical lesions
human papillomavirus (HPV)
colposcopic biopsy
human papillomavirus 52 (HPV52)
human papillomavirus 58
cervical cancer
title Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
title_full Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
title_fullStr Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
title_full_unstemmed Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
title_short Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
title_sort implications of persistent hpv52 and hpv58 positivity for the management of cervical lesions
topic cervical lesions
human papillomavirus (HPV)
colposcopic biopsy
human papillomavirus 52 (HPV52)
human papillomavirus 58
cervical cancer
url https://www.frontiersin.org/articles/10.3389/fonc.2022.812076/full
work_keys_str_mv AT baozhuyi implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions
AT qianxu implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions
AT zhixuanzhang implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions
AT jinyizhang implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions
AT yixu implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions
AT luoqihuang implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions
AT yuehu implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions
AT quanmeitu implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions
AT jingyunchen implicationsofpersistenthpv52andhpv58positivityforthemanagementofcervicallesions